Flomax Review: Great For Boehringer Ingelheim, Generic Better For Your Wallet, Costs A Tiny Fraction of Flomax
Thanks to Consumer Reports for its review of Flomax, which its manufacturer, Boehringer Ingelheim spent more than $100 million advertising on television last year.
The marketing campaign work, for BI, racking up sales of more than $1 billion last year.
But for patients, Consumer Reports says it reviewed evidence from 60 studies and found that the generic drug Doxazosin works just as well.
The difference in price: Flomax is more than $200 a month, Doxazosin is less than $10.
That is a 2,000 percent difference.
Go to www.consumerreportshealth.org for more free information on drugs and how you can save HUGE.
Similar Posts:
- How To Save Money While Lowering Your Bad Cholesterol, Raising Your Good
- Save Money On Medicine, Switching To Generics Can Save You A Fortune
- Three Drug Companies Pay Fines For Blocking Generics
- Diabetes Drugs: Consumer Reports Provides You With The Best, Least Expensive
- Conn Officials Turn Up The Heat On Rite Aid Price Increases
1 Response for “Flomax Review: Great For Boehringer Ingelheim, Generic Better For Your Wallet, Costs A Tiny Fraction of Flomax”
Leave a Reply
Advertisements
Generics are the way to go…they’re the bioequivalent to name brand drugs and cost a lot less. Check out a new website called ‘Medtipster’ that enables you to locate low-cost, generic prescriptions from reputable pharmacies in your area. You just tell the site what you need and your zip code and Medtipster will direct you to the least expensive retailer…google search “Medtipster” and have a look.